(Phoenix, AZ) – In fourth quarter 2009 Derma Health Institute saw a significant increase in injectables like Botox and Dysport as well as facial fillers like Juvederm and Perlane. A recent survey conducted by MEDACorp uncovered similar results, reporting these procedures had increased nationwide for the first time since the economic downturn began in 2007. Findings like this may indicate consumers are beginning to feel a sense of economic optimism.
“Last year our Botox and Dysport business increased by 115% and our Juvederm and Perlane business increased 89%,” said Trish Gulbranson, Derma Health Institute owner. “This is a positive sign that patients feel like the market is starting to turn around.”
In this economic climate companies like Allergan, the maker of Botox, have also increased their customer service programs. They recently started a promotion called Brilliant Distinctions, which encourages customers to sign up for an email list and get up to $50 in credit towards their first Botox visit at Derma Health Institute. Patients then receive emails every 4-6 months reminding them to make their next Botox appointment. According to Gulbranson customers absolutely love this VIP service.
“The nice thing about Botox and Juvederm is that they’re a quick fix, minimally invasive and provide instant results. We’ve seen a decrease in the cost of both these products in the last few years. An average woman can get Botox for about $250 and get rid of that ‘angry line’ between their eyes. Juvederm treatments have also decreased in cost to from $600 a syringe to $399. With these, patients come out looking years younger, rejuvenated and relaxed.”
Derma Health Institute has earned the highest certification level awarded by Allergan, Black Diamond. As one of the largest providers of Botox and Juvederm in the nation, they have an immense amount of experience and results with these procedures.
For more information on Botox, Juvederm or other filler options, contact Derma Health Institute in Mesa/Gilbert at (480) 539-0777, Chandler/Tempe at (480) 730-9000, Ahwatukee/Phoenix at (480) 460-1505 or Paradise Valley/Scottsdale at (480) 991-7900.
http://www.dermahealthinstitute.com
Showing posts with label Dysport. Show all posts
Showing posts with label Dysport. Show all posts
Wednesday, February 17, 2010
Wednesday, January 6, 2010
Botox and Dysport Safety/Danger Information You Should Know
We’ve all heard of DIY home repairs, but DIY Botox and laser treatments? Yes, in this economy many people are looking at cutting costs, but before you start injecting yourself with cosmetic injectables or using a laser on yourself, you need to evaluate the potential life threatening risks.
Injecting foam insulation around a drafty electrical socket is one thing, but injecting oneself with a botulinum toxin product is quite another. Consumers need to be aware that engaging in DIY laser treatments or cosmetic injectables carry with it a great deal of risk vs. reward. Consumers interested in cosmetic injectable procedures should always engage a professionally-trained physician to administer these treatments. Patients should choose doctors who have completed a comprehensive Botox Training program.
The International Association of Physicians for Aesthetic Medicine (IAPAM) (http://www.iapam.com), offers consumers the following 4 “tips” on how to ensure their aesthetic medicine treatment is both safe and effective.
Tip One: Botox buyer beware
Recently, there have been several reports regarding DIY “botox-like” injectables, which can be purchased through the internet. A woman in Texas offered consumers a botox-like product called “Freeze,” complete with a “How-To” video, so consumers could administer the botulinum toxin themselves. The red-flags regarding this internet offering range from her unrealistically low pricing to her lack of knowledge regarding the potential side affects that can accompany the administration of a neurotoxin into the body.
In this instance, the vendor was offering 100 unit vial of “Freeze” for $139, where the physician cost for a 100 unit vial of Botox Cosmetic® is over $500. Equally, for Dysport, she was quoting $169 US for a 500 unit vial, where a 300 unit vial in the US is sold to physicians for $475. “As the saying goes if its too good to be true, than it probably is,” says IAPAM Executive-Director Jeff Russell. “If you see someone selling a cosmetic injectable on the internet for a quarter of the cost to physicians, then the product is most likely counterfeit and you have no idea what is actually in it,” continues Russell.
Furthermore, “it’s important to ensure the vial being used is not counterfeit, look for the 3-d hologram to ensure its is the FDA approved product,” says Jeff Russell. Single-use vials of BOTOX Cosmetic® have a holographic film on the vial label that contains the name “Allergan” within horizontal lines of rainbow color. To see the hologram, rotate the vial back and forth between your fingers under a desk lamp or fluorescent light.
The FDA offers these salient “tips” to consumers considering botulinum toxin injectables:
* Know what you are being injected with and make sure your health care professional is using only an FDA-approved product, purchased within the United States. Patients and doctors alike can verify that the product they are receiving is an FDA-approved and licensed botulinum toxin type A medical product.
* If your doctor refuses to give you this information, look for another health care professional.
As well, if your vial is not in English, this is another red flag. Some physicians buy their cosmetic injectables from Mexico and Canada where they often originate in China and Eastern Europe. These vials are not FDA approved, and therefore you have no idea what is actually in the vial. You should ask your provider if they purchased their injectable products directly from the US distributor.
Dr. Russ Kridel, respected Houston facial plastic surgeon, and member of The American Medical Association Council on Science and Public Health agrees. “Patients need to be cautious when injectables are offered at bargain prices, because they may have been obtained through web sites or offshore; they may be counterfeit and there’s no one to assure purity or content! Serious injury or personal harm may result when unknown substances are injected.”
Such was the case in 2004 in Florida, where the Office of Criminal Investigations of the FDA found that the resulting cases of botulism in four patients, who became ill after cosmetic injectable treatments, were a product of the illegal administration of enormous amounts of unlicensed and unapproved botulinum toxin by an unlicensed physician.
Tip Two: Cosmetic injectables need to be prescribed by a physician
Botox Cosmetic and Dysport are FDA controlled substances, and can only be sold to licensed physicians for administration.
Dr. Melissa Babcock, board-certified dermatologist and Mohs Surgeon practicing in the Atlanta area, offers this sage advice to consumers: “If you are not a trained medical professional, botulinum toxin (Botox or Dysport) can be very dangerous to use. Medical professionals are trained to dilute the concentrated product correctly, inject it correctly into appropriate muscles and use the correct concentration for each muscle they are injecting. As a physician with a lot of experience injecting Botox, I am very concerned for a patient that may try to buy and inject their own Botox.”
Also, reputable physicians only buy their cosmetic injectable product directly from the US division of the pharmaceutical company (i.e. Botox Cosmetic and Juvederm are only available from Allergan, Inc. in Irvine, CA; and Dysport, Restylane, Perlane are only available for purchase from Medicis, Inc. in Scottsdale, AZ).
Tip Three: Know the Risks
The FDA offers additional tips to consumers regarding understanding the risks associated with botulinum toxin:
* Make sure the benefits and risks are fully explained to you in a patient consultation.
* Fully disclose any medical conditions you might have and medications you are taking, including vitamins and over-the-counter drugs.
* Botulinum toxin products should be administered in an appropriate setting using sterile instruments. Malls, private homes, [hotel rooms, and conference rooms] are not medical environments and may be unsanitary.
Dr. Kridel also comments on the risks associated with neurotoxin injectables. “Doctors’ offices are probably the safest place to have such injectables administered. Not too many spas, peoples’ homes, or hotel rooms have the same standards for cleanliness and emergency care that a doctor’s office does!”
Dr. Babcock offers equally potent advice to patients regarding the real dangers associated with self-injecting botulinum toxin. “An untrained person injecting Botox would certainly experience side effects such as drooping eyelids, and other facial distortions resembling a person who suffered a stroke. My message to patients: Botox is a powerful medication that when used correctly can make beautiful results. When used incorrectly the results can be disastrous. Save your money, go to a medical professional and don’t try Botox at home!”
Tip Four: Choose a physician who is comprehensively trained in all cosmetic injectable outcomes
Dr. Kridel emphasizes the importance of engaging a trained and experienced physician in the administration of injectables. “The practice of medicine is defined by the diagnosis and treatment of a problem. Is an aesthetician or nurse deciding on their own what injectable is appropriate for you and how much you should get? Or is the physician first seeing you, discussing the options and then deciding, based on your medical history and his exam, what should be done—the preferable route—and is that doctor relaying on alternatives to that injectable? And what kind of physician is doing the injecting or the supervision? Is the physician one who routinely treats such conditions?
Furthermore, Dr. Kridel encourages patients to seek out medical practices where, “staff are trained in sterile procedures so as to avoid contamination, re-use of needles, and infections. Plus, in the rare case of an allergic reaction, [ensure] staff and physicians are trained in resuscitative measures and have emergency drugs available.”
The FDA also cautions that there is a possibility of experiencing potentially life-threatening distant spread of toxin effect from the injection site after local injection. However, distant spread of BOTOX cosmeitc resulting in serious side effects has never been reported to the FDA.
Also, doctors administering botulinum toxin understand that products are not interchangeable, and that clinical doses expressed in units are not comparable from one botulinum toxin product to the next (e.g. Botox Cosmetic® vs. Dysport®). Units of one product cannot be converted into units of another product.
Given these risks, patients should insist on engaging physicians who have completed comprehensive, clinical training programs like the IAPAM’s Aesthetic Medicine Symposium or Advanced Botox /Dermal Filler Bootcamp.” For the patient, this translates into ensuring that their physician is trained in the latest injection techniques, is comfortable with dealing with a possible adverse event due to the procedure and is a member of a internationally recognized aesthetic association.
The Last Word
Dr. Brian R. Buinewicz offers these closing thoughts to consumers foolishly considering DIY cosmetic injectables.
“This is incredibly concerning that someone would be so short sighted [as to consider] DIY Botox. Botulinum toxin A is a drug that, if administered incorrectly, can have serious and potentially fatal side effects. To take the chance of a serious or fatal reaction to save a few bucks and for convenience is beyond reason. Would someone perform their own appendectomy or Cesarean section because it was convenient for them and they could save on anesthesia and hospital costs?”
Understandably, consumers will continue to look for opportunities to forgo expensive professional services, ranging from a basic handyman to an accountant. However, in every instance where a consumer chooses the DIY option over the “do it for me” option, the key question has to be: risk vs. reward, and the issues of risk associated with the DIY applications in aesthetic medicine are significant.
Dr. Kridel reminds patients that “what is exciting now are all the FDA approved injectables that we now have,” giving many choices to doctors and patients to individualize the right treatment. It’s just wise to have the right physician examining and guiding you to the optimal result!” Ultimately, the wisest consumers will opt to save money through DIY home decorating, and not aesthetic medicine procedures.
-compiled by Leslie Marshall, Online Media and Research Specialist, The IAPAM.
More more information:
Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 x705
e-mail: info@theiapam.com
web: http://www.iapam.com
Injecting foam insulation around a drafty electrical socket is one thing, but injecting oneself with a botulinum toxin product is quite another. Consumers need to be aware that engaging in DIY laser treatments or cosmetic injectables carry with it a great deal of risk vs. reward. Consumers interested in cosmetic injectable procedures should always engage a professionally-trained physician to administer these treatments. Patients should choose doctors who have completed a comprehensive Botox Training program.
The International Association of Physicians for Aesthetic Medicine (IAPAM) (http://www.iapam.com), offers consumers the following 4 “tips” on how to ensure their aesthetic medicine treatment is both safe and effective.
Tip One: Botox buyer beware
Recently, there have been several reports regarding DIY “botox-like” injectables, which can be purchased through the internet. A woman in Texas offered consumers a botox-like product called “Freeze,” complete with a “How-To” video, so consumers could administer the botulinum toxin themselves. The red-flags regarding this internet offering range from her unrealistically low pricing to her lack of knowledge regarding the potential side affects that can accompany the administration of a neurotoxin into the body.
In this instance, the vendor was offering 100 unit vial of “Freeze” for $139, where the physician cost for a 100 unit vial of Botox Cosmetic® is over $500. Equally, for Dysport, she was quoting $169 US for a 500 unit vial, where a 300 unit vial in the US is sold to physicians for $475. “As the saying goes if its too good to be true, than it probably is,” says IAPAM Executive-Director Jeff Russell. “If you see someone selling a cosmetic injectable on the internet for a quarter of the cost to physicians, then the product is most likely counterfeit and you have no idea what is actually in it,” continues Russell.
Furthermore, “it’s important to ensure the vial being used is not counterfeit, look for the 3-d hologram to ensure its is the FDA approved product,” says Jeff Russell. Single-use vials of BOTOX Cosmetic® have a holographic film on the vial label that contains the name “Allergan” within horizontal lines of rainbow color. To see the hologram, rotate the vial back and forth between your fingers under a desk lamp or fluorescent light.
The FDA offers these salient “tips” to consumers considering botulinum toxin injectables:
* Know what you are being injected with and make sure your health care professional is using only an FDA-approved product, purchased within the United States. Patients and doctors alike can verify that the product they are receiving is an FDA-approved and licensed botulinum toxin type A medical product.
* If your doctor refuses to give you this information, look for another health care professional.
As well, if your vial is not in English, this is another red flag. Some physicians buy their cosmetic injectables from Mexico and Canada where they often originate in China and Eastern Europe. These vials are not FDA approved, and therefore you have no idea what is actually in the vial. You should ask your provider if they purchased their injectable products directly from the US distributor.
Dr. Russ Kridel, respected Houston facial plastic surgeon, and member of The American Medical Association Council on Science and Public Health agrees. “Patients need to be cautious when injectables are offered at bargain prices, because they may have been obtained through web sites or offshore; they may be counterfeit and there’s no one to assure purity or content! Serious injury or personal harm may result when unknown substances are injected.”
Such was the case in 2004 in Florida, where the Office of Criminal Investigations of the FDA found that the resulting cases of botulism in four patients, who became ill after cosmetic injectable treatments, were a product of the illegal administration of enormous amounts of unlicensed and unapproved botulinum toxin by an unlicensed physician.
Tip Two: Cosmetic injectables need to be prescribed by a physician
Botox Cosmetic and Dysport are FDA controlled substances, and can only be sold to licensed physicians for administration.
Dr. Melissa Babcock, board-certified dermatologist and Mohs Surgeon practicing in the Atlanta area, offers this sage advice to consumers: “If you are not a trained medical professional, botulinum toxin (Botox or Dysport) can be very dangerous to use. Medical professionals are trained to dilute the concentrated product correctly, inject it correctly into appropriate muscles and use the correct concentration for each muscle they are injecting. As a physician with a lot of experience injecting Botox, I am very concerned for a patient that may try to buy and inject their own Botox.”
Also, reputable physicians only buy their cosmetic injectable product directly from the US division of the pharmaceutical company (i.e. Botox Cosmetic and Juvederm are only available from Allergan, Inc. in Irvine, CA; and Dysport, Restylane, Perlane are only available for purchase from Medicis, Inc. in Scottsdale, AZ).
Tip Three: Know the Risks
The FDA offers additional tips to consumers regarding understanding the risks associated with botulinum toxin:
* Make sure the benefits and risks are fully explained to you in a patient consultation.
* Fully disclose any medical conditions you might have and medications you are taking, including vitamins and over-the-counter drugs.
* Botulinum toxin products should be administered in an appropriate setting using sterile instruments. Malls, private homes, [hotel rooms, and conference rooms] are not medical environments and may be unsanitary.
Dr. Kridel also comments on the risks associated with neurotoxin injectables. “Doctors’ offices are probably the safest place to have such injectables administered. Not too many spas, peoples’ homes, or hotel rooms have the same standards for cleanliness and emergency care that a doctor’s office does!”
Dr. Babcock offers equally potent advice to patients regarding the real dangers associated with self-injecting botulinum toxin. “An untrained person injecting Botox would certainly experience side effects such as drooping eyelids, and other facial distortions resembling a person who suffered a stroke. My message to patients: Botox is a powerful medication that when used correctly can make beautiful results. When used incorrectly the results can be disastrous. Save your money, go to a medical professional and don’t try Botox at home!”
Tip Four: Choose a physician who is comprehensively trained in all cosmetic injectable outcomes
Dr. Kridel emphasizes the importance of engaging a trained and experienced physician in the administration of injectables. “The practice of medicine is defined by the diagnosis and treatment of a problem. Is an aesthetician or nurse deciding on their own what injectable is appropriate for you and how much you should get? Or is the physician first seeing you, discussing the options and then deciding, based on your medical history and his exam, what should be done—the preferable route—and is that doctor relaying on alternatives to that injectable? And what kind of physician is doing the injecting or the supervision? Is the physician one who routinely treats such conditions?
Furthermore, Dr. Kridel encourages patients to seek out medical practices where, “staff are trained in sterile procedures so as to avoid contamination, re-use of needles, and infections. Plus, in the rare case of an allergic reaction, [ensure] staff and physicians are trained in resuscitative measures and have emergency drugs available.”
The FDA also cautions that there is a possibility of experiencing potentially life-threatening distant spread of toxin effect from the injection site after local injection. However, distant spread of BOTOX cosmeitc resulting in serious side effects has never been reported to the FDA.
Also, doctors administering botulinum toxin understand that products are not interchangeable, and that clinical doses expressed in units are not comparable from one botulinum toxin product to the next (e.g. Botox Cosmetic® vs. Dysport®). Units of one product cannot be converted into units of another product.
Given these risks, patients should insist on engaging physicians who have completed comprehensive, clinical training programs like the IAPAM’s Aesthetic Medicine Symposium or Advanced Botox /Dermal Filler Bootcamp.” For the patient, this translates into ensuring that their physician is trained in the latest injection techniques, is comfortable with dealing with a possible adverse event due to the procedure and is a member of a internationally recognized aesthetic association.
The Last Word
Dr. Brian R. Buinewicz offers these closing thoughts to consumers foolishly considering DIY cosmetic injectables.
“This is incredibly concerning that someone would be so short sighted [as to consider] DIY Botox. Botulinum toxin A is a drug that, if administered incorrectly, can have serious and potentially fatal side effects. To take the chance of a serious or fatal reaction to save a few bucks and for convenience is beyond reason. Would someone perform their own appendectomy or Cesarean section because it was convenient for them and they could save on anesthesia and hospital costs?”
Understandably, consumers will continue to look for opportunities to forgo expensive professional services, ranging from a basic handyman to an accountant. However, in every instance where a consumer chooses the DIY option over the “do it for me” option, the key question has to be: risk vs. reward, and the issues of risk associated with the DIY applications in aesthetic medicine are significant.
Dr. Kridel reminds patients that “what is exciting now are all the FDA approved injectables that we now have,” giving many choices to doctors and patients to individualize the right treatment. It’s just wise to have the right physician examining and guiding you to the optimal result!” Ultimately, the wisest consumers will opt to save money through DIY home decorating, and not aesthetic medicine procedures.
-compiled by Leslie Marshall, Online Media and Research Specialist, The IAPAM.
More more information:
Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 x705
e-mail: info@theiapam.com
web: http://www.iapam.com
Monday, August 31, 2009
Men Around the World Seek Cosmetic Surgery
Men in increasing numbers around the world are using cosmetic surgery, driven by the credit crunch and 'man boobs.' The number of male breast reduction procedures carried out is growing rapidly.
MANCHESTER, England, Aug. 2 /PRNewswire/ -- Cosmetic Surgery Guru reveals that men around the world are turning to cosmetic surgery in increasing numbers, driven by the recent economic downturn and a growing concern over "moobs" ("man boobs".)
For more information about Derma Health Institute, see:
http://www.dermahealthinstitute.com
Male cosmetic surgery rates are not only growing in America, the UK and other countries where the stigma attached to male cosmetic surgery has all but disappeared, but in the Middle East too. According to the Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM), men now account for one in every five of Dubai's cosmetic surgery patients.
Although non-invasive treatments like Botox and laser hair removal for the back are the most common amongst men, surgical procedures, particularly male breast reduction, are becoming increasingly popular.
Credit Crunch
Public interest in cosmetic surgery has remained strong, despite the credit crunch. Men worldwide are looking to cosmetic surgery to boost their performance in an increasingly competitive job market. Some men who have been made redundant are using cosmetic surgery for therapeutic reasons: to improve self-esteem.
In Dubai, low oil prices and other negative economic factors have caused many people financial problems. Such problems have inspired men to invest in hair and beauty treatments as well as surgery, to boost their employment status as well as their confidence. The DCAAM predict that by 2013, men in Dubai will be spending $100 billion on cosmetic surgery each year.
"Moobs"
Gynaecomastia, enlargement of the male breast tissue, is becoming a serious concern to a growing number of men worldwide. Bryan Mayou of London's Cadogan Clinic sees "an increasing number of men coming into (his) clinic with body-image problems and low self-esteem because of this particular condition."
Gynaecomastia currently affects 40-60% of men to varying degrees, although this figure is set to rise in line with obesity rates. Some scientists blame high levels of the female hormone oestrogen in food and drink for accentuating the problem. Men feel most inhibited by the condition in summer months, when they would normally remove clothing in hot weather or when swimming.
According to the British Association of Aesthetic Plastic Surgeons (BAAPS), 44% more male breast reduction surgeries have taken place this year compared with last. In Scotland, this figure is closer to 80%. The male breast reduction process, which takes place under general anaesthetic, involves making small incisions under the armpits of the patient so that liposuction can be used to remove excess fat from the breast area.
In the UK, where men account for 10% of all cosmetic surgery patients, breast reduction has replaced the facelift as the fifth most popular male cosmetic surgery procedure. 323 male breast reduction procedures were carried out last year, compared with just 22 five years ago.
Cosmetic Surgery Guru is a free and accessible website dedicated to informing the public of new and exciting developments in cosmetic surgery.
http://www.cosmeticsurgeryguru.com
For more information about Derma Health Institute, see:
http://www.dermahealthinstitute.com
SOURCE Cosmetic Surgery Guru
MANCHESTER, England, Aug. 2 /PRNewswire/ -- Cosmetic Surgery Guru reveals that men around the world are turning to cosmetic surgery in increasing numbers, driven by the recent economic downturn and a growing concern over "moobs" ("man boobs".)
For more information about Derma Health Institute, see:
http://www.dermahealthinstitute.com
Male cosmetic surgery rates are not only growing in America, the UK and other countries where the stigma attached to male cosmetic surgery has all but disappeared, but in the Middle East too. According to the Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM), men now account for one in every five of Dubai's cosmetic surgery patients.
Although non-invasive treatments like Botox and laser hair removal for the back are the most common amongst men, surgical procedures, particularly male breast reduction, are becoming increasingly popular.
Credit Crunch
Public interest in cosmetic surgery has remained strong, despite the credit crunch. Men worldwide are looking to cosmetic surgery to boost their performance in an increasingly competitive job market. Some men who have been made redundant are using cosmetic surgery for therapeutic reasons: to improve self-esteem.
In Dubai, low oil prices and other negative economic factors have caused many people financial problems. Such problems have inspired men to invest in hair and beauty treatments as well as surgery, to boost their employment status as well as their confidence. The DCAAM predict that by 2013, men in Dubai will be spending $100 billion on cosmetic surgery each year.
"Moobs"
Gynaecomastia, enlargement of the male breast tissue, is becoming a serious concern to a growing number of men worldwide. Bryan Mayou of London's Cadogan Clinic sees "an increasing number of men coming into (his) clinic with body-image problems and low self-esteem because of this particular condition."
Gynaecomastia currently affects 40-60% of men to varying degrees, although this figure is set to rise in line with obesity rates. Some scientists blame high levels of the female hormone oestrogen in food and drink for accentuating the problem. Men feel most inhibited by the condition in summer months, when they would normally remove clothing in hot weather or when swimming.
According to the British Association of Aesthetic Plastic Surgeons (BAAPS), 44% more male breast reduction surgeries have taken place this year compared with last. In Scotland, this figure is closer to 80%. The male breast reduction process, which takes place under general anaesthetic, involves making small incisions under the armpits of the patient so that liposuction can be used to remove excess fat from the breast area.
In the UK, where men account for 10% of all cosmetic surgery patients, breast reduction has replaced the facelift as the fifth most popular male cosmetic surgery procedure. 323 male breast reduction procedures were carried out last year, compared with just 22 five years ago.
Cosmetic Surgery Guru is a free and accessible website dedicated to informing the public of new and exciting developments in cosmetic surgery.
http://www.cosmeticsurgeryguru.com
For more information about Derma Health Institute, see:
http://www.dermahealthinstitute.com
SOURCE Cosmetic Surgery Guru
Friday, July 31, 2009
Dosage Unit Size/Price Differences Between Botox and Dysport
Confused about the dosage differences between Botox and Dysport?
It is important to know that the unit size of Dysport is smaller than the unit size of Botox. According to the FDA, it takes a minimum of two times more units of Dysport to get the same effect as Botox. So, if you've gotten Botox and received 20 units, you'll need 40 units of Dysport for an equivalent treatment.
See the chart below for a comparison of Botox and Dysport units needed and price:
Botox @ $9.99 = unit Dysport @ $3.99 = unit
20 Units = $199.80 40 Units = $159.60
25 Units = $249.75 50 Units = $199.50
30 Units = $299.70 60 Units = $239.40
35 Units = $349.65 70 Units = $279.30
40 Units = $399.60 80 Units = $319.20
45 Units = $449.55 90 Units = $359.10
50 Units = $499.50 100 Units = $399.00
55 Units = $549.45 110 Units = $348.90
60 Units = $599.40 120 Units = $478.80
This article was published on Tuesday 23 June, 2009.
It is important to know that the unit size of Dysport is smaller than the unit size of Botox. According to the FDA, it takes a minimum of two times more units of Dysport to get the same effect as Botox. So, if you've gotten Botox and received 20 units, you'll need 40 units of Dysport for an equivalent treatment.
See the chart below for a comparison of Botox and Dysport units needed and price:
Botox @ $9.99 = unit Dysport @ $3.99 = unit
20 Units = $199.80 40 Units = $159.60
25 Units = $249.75 50 Units = $199.50
30 Units = $299.70 60 Units = $239.40
35 Units = $349.65 70 Units = $279.30
40 Units = $399.60 80 Units = $319.20
45 Units = $449.55 90 Units = $359.10
50 Units = $499.50 100 Units = $399.00
55 Units = $549.45 110 Units = $348.90
60 Units = $599.40 120 Units = $478.80
This article was published on Tuesday 23 June, 2009.
Shipping Begins for Botox Rival Dysport for Wrinkles Reduction
SCOTTSDALE, Ariz., June 15, 2009 -- Medicis (NYSE:MRX) today announced that the Company has begun shipment to physicians of DYSPORT(TM) (abobotulinumtoxinA) for the treatment of glabellar lines. DYSPORT is an acetylcholine release inhibitor and a neuromuscular blocking agent, approved by the U.S. Food and Drug Administration (FDA) in late April 2009. The approval included two separate indications, the treatment of cervical dystonia in adults to reduce the severity of abnormal head position and neck pain, and the temporary improvement in the appearance of moderate to severe glabellar lines in adults younger than 65 years of age. Medicis has rights to market DYSPORT in the United States for the aesthetic indication (glabellar lines).
Contact Derma Health Institute if you're interested in trying Dysport in the Phoenix metro area, including Ahwatukee, Chandler, Gilbert, Mesa, Phoenix, and Paradise Valley, Arizona. http://www.dermahealthinstitute.com
"We are pleased to be introducing into the U.S. what we believe may be the most important launch in the aesthetic marketplace since RESTYLANE(R)," said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. "We have been very encouraged by the initial response from physicians' preorders, and are eager to provide them with a worthy competitor in this multi-million dollar market. Additionally, we are grateful to our partners at Ipsen for their collaborative efforts in making this launch possible."
McKesson is the U.S. distributor of DYSPORT for glabellar lines. Physicians in the U.S. may place orders by calling McKesson directly at 1-877-520-0500.
About the U.S. Aesthetic Market
According to the American Society for Aesthetic Plastic Surgery, over 10 million cosmetic procedures were performed in the U.S. in 2008, 83% of which represented nonsurgical procedures. Injections of botulinum toxin type A have been the number one nonsurgical cosmetic procedure for the past five years, with over 2.4 million total procedures in 2008 alone.(1) The U.S. aesthetic market for botulinum toxin type A is estimated to be approximately $300 million to $400 million.(2)
DYSPORT Important Safety Information
The effects of DYSPORT and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms.
The dosing Units of DYSPORT are not the same as and are not interchangeable with those of other botulinum toxin products.
Recommended dose and frequency of administration should not be exceeded.
Caution should be exercised when administering DYSPORT to patients with surgical alterations to the facial anatomy, marked facial asymmetry, inflammation at the injection site(s), ptosis, excessive dermatochalasis, deep dermal scarring or thick sebaceous skin.
The clinical effects of treatment may be exacerbated in patients with neuromuscular disorders.
DYSPORT is contraindicated in patients with infection at the proposed injection site, an allergy to cow's-milk protein or a known hypersensitivity to any botulinum toxin product or its components.
DYSPORT is not recommended for use in children or pregnant women.
In clinical studies, the most frequently reported adverse events (> or = 2%) were nasopharyngitis, headache, injection site pain, injection site reaction, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis and nausea.
To view the Full Prescribing Information and Patient Medication Guide, visit www.DysportUSA.com.
To report SUSPECTED ADVERSE REACTIONS, call 1-877-397-7671 or FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.
About DYSPORT (abobotulinumtoxinA)
The active substance in DYSPORT is a botulinum neurotoxin type A complex, which acts at the level of the neuromuscular junction in the targeted muscle. DYSPORT is a neuromuscular blocking toxin which acts to block acetylcholine release at motor nerve ends and reduces muscular spasm.
Used in patient care in the United Kingdom since 1991, DYSPORT has marketing authorizations in 76 countries for therapeutic use and in 27 countries for aesthetic use.
DYSPORT was initially developed and subsequently approved in many markets around the world, outside the U.S., for the treatment of movement disorders such as cervical dystonia (spasmodic torticollis), blepharospasm (involuntary eye closure), hemifacial spasm and various forms of muscle spasticity, including post-stroke arm spasticity, spasticity of the lower limbs (calf) in adults and children with cerebral palsy. It was later developed for the treatment of a wide variety of neuromuscular disorders and aesthetic medicine.
Contact Derma Health Institute if you're interested in trying Dysport in the Phoenix metro area, including Ahwatukee, Chandler, Gilbert, Mesa, Phoenix, and Paradise Valley, Arizona.
http://www.dermahealthinstitute.comd
About Medicis
Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. Medicis is dedicated to helping patients attain a healthy and youthful appearance and self-image. Medicis has leading branded prescription products in a number of therapeutic and aesthetic categories. Medicis' products have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and aesthetic elegance.
Medicis' products include the brands DYSPORT(TM) (abobotulinumtoxinA), RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) (sodium phenylbutyrate) Tablets and Powder, AMMONUL(R) (sodium phenylacetate and sodium benzoate) Injection 10%/10%, the LIPOSONIX(R)(3) system and the over-the-counter brand ESOTERICA(R).
For more information about Medicis, please visit the Company's website at www.Medicis.com. Printed copies of Medicis' complete audited financial statements are available free of charge upon request.
Medicis Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. All statements included in this press release that address activities, events or developments that Medicis expects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. Examples of such forward-looking statements include, but are not limited to, the expected importance of the product launch and the anticipated ability of DYSPORT to compete in the aesthetic marketplace. These statements are based on certain assumptions made by Medicis based on its experience and perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. No assurances can be given, however, that these activities, events or developments will occur or that such results will be achieved. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of Medicis. Several of these risks are outlined in Medicis' most recent annual report on Form 10-K for the year ended December 31, 2008, and other documents Medicis files with the Securities and Exchange Commission. Forward-looking statements represent the judgment of Medicis' management as of the date of this release, and Medicis disclaims any intent or obligation to update any forward-looking statements contained herein, which speak as of the date hereof.
NOTE: Full prescribing information for any Medicis prescription product is available by contacting the Company. All trademarks are the property of their respective owners.
(1) American Society for Aesthetic Plastic Surgery, Cosmetic Surgery National Data Bank Statistics, 2008
(2) Competitor company reports
(3) The LIPOSONIX(R) system is not cleared for sale in the U.S.
CONTACT: Medicis
Kara Stancell
(480) 291-5854
Contact Derma Health Institute if you're interested in trying Dysport in the Phoenix metro area, including Ahwatukee, Chandler, Gilbert, Mesa, Phoenix, and Paradise Valley, Arizona. http://www.dermahealthinstitute.com
"We are pleased to be introducing into the U.S. what we believe may be the most important launch in the aesthetic marketplace since RESTYLANE(R)," said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. "We have been very encouraged by the initial response from physicians' preorders, and are eager to provide them with a worthy competitor in this multi-million dollar market. Additionally, we are grateful to our partners at Ipsen for their collaborative efforts in making this launch possible."
McKesson is the U.S. distributor of DYSPORT for glabellar lines. Physicians in the U.S. may place orders by calling McKesson directly at 1-877-520-0500.
About the U.S. Aesthetic Market
According to the American Society for Aesthetic Plastic Surgery, over 10 million cosmetic procedures were performed in the U.S. in 2008, 83% of which represented nonsurgical procedures. Injections of botulinum toxin type A have been the number one nonsurgical cosmetic procedure for the past five years, with over 2.4 million total procedures in 2008 alone.(1) The U.S. aesthetic market for botulinum toxin type A is estimated to be approximately $300 million to $400 million.(2)
DYSPORT Important Safety Information
The effects of DYSPORT and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms.
The dosing Units of DYSPORT are not the same as and are not interchangeable with those of other botulinum toxin products.
Recommended dose and frequency of administration should not be exceeded.
Caution should be exercised when administering DYSPORT to patients with surgical alterations to the facial anatomy, marked facial asymmetry, inflammation at the injection site(s), ptosis, excessive dermatochalasis, deep dermal scarring or thick sebaceous skin.
The clinical effects of treatment may be exacerbated in patients with neuromuscular disorders.
DYSPORT is contraindicated in patients with infection at the proposed injection site, an allergy to cow's-milk protein or a known hypersensitivity to any botulinum toxin product or its components.
DYSPORT is not recommended for use in children or pregnant women.
In clinical studies, the most frequently reported adverse events (> or = 2%) were nasopharyngitis, headache, injection site pain, injection site reaction, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis and nausea.
To view the Full Prescribing Information and Patient Medication Guide, visit www.DysportUSA.com.
To report SUSPECTED ADVERSE REACTIONS, call 1-877-397-7671 or FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.
About DYSPORT (abobotulinumtoxinA)
The active substance in DYSPORT is a botulinum neurotoxin type A complex, which acts at the level of the neuromuscular junction in the targeted muscle. DYSPORT is a neuromuscular blocking toxin which acts to block acetylcholine release at motor nerve ends and reduces muscular spasm.
Used in patient care in the United Kingdom since 1991, DYSPORT has marketing authorizations in 76 countries for therapeutic use and in 27 countries for aesthetic use.
DYSPORT was initially developed and subsequently approved in many markets around the world, outside the U.S., for the treatment of movement disorders such as cervical dystonia (spasmodic torticollis), blepharospasm (involuntary eye closure), hemifacial spasm and various forms of muscle spasticity, including post-stroke arm spasticity, spasticity of the lower limbs (calf) in adults and children with cerebral palsy. It was later developed for the treatment of a wide variety of neuromuscular disorders and aesthetic medicine.
Contact Derma Health Institute if you're interested in trying Dysport in the Phoenix metro area, including Ahwatukee, Chandler, Gilbert, Mesa, Phoenix, and Paradise Valley, Arizona.
http://www.dermahealthinstitute.comd
About Medicis
Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. Medicis is dedicated to helping patients attain a healthy and youthful appearance and self-image. Medicis has leading branded prescription products in a number of therapeutic and aesthetic categories. Medicis' products have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and aesthetic elegance.
Medicis' products include the brands DYSPORT(TM) (abobotulinumtoxinA), RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) (sodium phenylbutyrate) Tablets and Powder, AMMONUL(R) (sodium phenylacetate and sodium benzoate) Injection 10%/10%, the LIPOSONIX(R)(3) system and the over-the-counter brand ESOTERICA(R).
For more information about Medicis, please visit the Company's website at www.Medicis.com. Printed copies of Medicis' complete audited financial statements are available free of charge upon request.
Medicis Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. All statements included in this press release that address activities, events or developments that Medicis expects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. Examples of such forward-looking statements include, but are not limited to, the expected importance of the product launch and the anticipated ability of DYSPORT to compete in the aesthetic marketplace. These statements are based on certain assumptions made by Medicis based on its experience and perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. No assurances can be given, however, that these activities, events or developments will occur or that such results will be achieved. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of Medicis. Several of these risks are outlined in Medicis' most recent annual report on Form 10-K for the year ended December 31, 2008, and other documents Medicis files with the Securities and Exchange Commission. Forward-looking statements represent the judgment of Medicis' management as of the date of this release, and Medicis disclaims any intent or obligation to update any forward-looking statements contained herein, which speak as of the date hereof.
NOTE: Full prescribing information for any Medicis prescription product is available by contacting the Company. All trademarks are the property of their respective owners.
(1) American Society for Aesthetic Plastic Surgery, Cosmetic Surgery National Data Bank Statistics, 2008
(2) Competitor company reports
(3) The LIPOSONIX(R) system is not cleared for sale in the U.S.
CONTACT: Medicis
Kara Stancell
(480) 291-5854
Subscribe to:
Posts (Atom)